Luminist Capital’s AbbVie ABBV Stock Holding History

Luminist Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.48K	Buy	+34	New	+$7.32K	0.01%	226
2026 Q1	–	Sell	-21	Closed	-$4.88K	–	111
2025 Q4	$4.88K	Sell	21 -24	-53%	-$5.47K	0.01%	182
2025 Q3	$11K	Buy	45 +24	+114%	+$4.89K	0.01%	172
2025 Q2	$4K	Hold	21	–	–	﹤0.01%	239
2025 Q1	$4.3K	Hold	21	–	–	﹤0.01%	181
2024 Q4	$3.67K	Buy	+21	New	+$3.86K	0.01%	171

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Luminist Capital's ABBV Position: Q2 2026 in Review

Luminist Capital opened a new position in AbbVie (ABBV) in Q2 2026: 34 shares worth $8.48K. The stake represents 0.01% of the portfolio and ranks #226 among its holdings. This is a return to the name: Luminist Capital previously reported a position in ABBV as recently as Q4 2025.

Luminist Capital first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $11K in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Luminist Capital held 34 shares of AbbVie worth $8.48K as of Q2 2026.
AbbVie was a new Luminist Capital position in Q2 2026.
AbbVie made up 0.01% of Luminist Capital's portfolio in Q2 2026, its #226 holding.
Luminist Capital first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Luminist Capital's AbbVie position peaked at $11K in Q3 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Luminist Capital's 13F filing for Q2 2026, filed 7 Aug 2026.